Displaying drugs 14601 - 14625 of 14853 in total
Dimethyl sulfone
Experimental
Investigational
Trichloroacetaldehyde
Experimental
Antimonous acid
Experimental
Methylphosphinic Acid
Experimental
2-Cyclopropylmethylenepropanal
Experimental
Lactaldehyde
Experimental
Propyl Trihydrogen Diphosphate
Experimental
Ethyl Dihydrogen Diphosphate
Experimental
Dibromothymoquinone
At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]
Experimental
ANA971
ANA971, an orally administered prodrug of isatoribine. Isatoribine is a nucleoside analog in development for the treatment of chronic hepatitis C virus (HCV) infection. ANA971 is a prodrug designed to improve the oral bioavailability of isatoribine. ANA971 resulted in higher levels of isatoribine in the blood than were present after...
Investigational
PROPYL-1-PHOSPHATE
Experimental
Lauroyl chloride
Experimental
ETC-1001
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational
Denibulin
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational
Betaine aldehyde
Experimental
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
Experimental
P-Hydroxybenzaldehyde
Experimental
AEOL-10150
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.
Investigational
2,3-Dimethyl-1,4-naphthoquinone
Experimental
Acetyl chloride
Experimental
Lawsone
Experimental
Displaying drugs 14601 - 14625 of 14853 in total